Epinephrine increased outflow facility and cyclic AMP in the in vitro
perfused human anterior segment with a maximal facility increase of 44
% occurring at approximately 2 x 10(-5) M. Cyclic AMP measured in the
perfusate from anterior segments increased by 12 - 14 fold after admin
istration of 10(-5) M epinephrine. Both the facility increase and cycl
ic AMP rise were blocked by the beta-2 selective antagonist, ICI118,55
1. While there was a correlation between the facility increase and ele
vation in cyclic AMP levels, the rise in cyclic AMP preceded the facil
ity increase by about 1 hour, suggesting that the ultimate effect of e
pinephrine involved a rather slow event such as synthesis and release
of prostaglandins or protein synthesis. Subsequent perfusion studies s
howed that very large concentrations of indomethacin were necessary to
block the outflow facility effect of epinephrine, suggesting that pro
staglandin synthesis did not underlie the facility effect in this syst
em. However, 5 x 10(-5) M cyclohexamide blocked the effect on outflow
facility of both epinephrine and forskolin, but did not block the rise
in cyclic AMP. These studies suggest that protein synthesis may play
a role in the epinephrine-induced facility increase at some point beyo
nd the second messenger level.